OBJECTIVES: The purpose of this study was to assess the risk of @entity260 after oral procedures performed under continued mono or dual anticoagulation therapy with @entity3925 (and @entity117 ). METHODS: This retrospective single-center observational study included 52 oral procedures performed under continued oral anticoagulant therapy with @entity3925 (20  mg/day). Among them, two procedures were performed under continued dual therapy with @entity117 (100  mg/day) added to the regimen. @entity86 events were compared with 285 oral procedures in @entity1 without any anticoagulation/antiplatelet therapy. RESULTS: @entity86 complications after oral surgery occurred significantly more often in @entity1 under continued @entity3925 therapy (11.5  %) than in the control cases without anticoagulation/antiplatelet medication (0.7  %). All of the @entity548 events were manageable: Two of them were treated with local compression, three by applying new fibrin glue with (one case) or without (two cases) secondary sutures, one occurred during a weekend and was therefore treated under inpatient conditions with suture replacement. All @entity86 episodes occurred during the first postoperative week. CONCLUSIONS: According to our data, continued anticoagulation therapy with @entity3925 significantly increases @entity86 risk for oral surgical procedures, although the @entity548 events were manageable. CLINICAL RELEVANCE: Oral surgeons, cardiologists, general physicians, and @entity1 should be aware of the increased @entity548 risk after oral surgical procedures. Close observation up to 1  week postoperatively is advisable to prevent excessive @entity548 .

@entity86 risk for oral surgery under continued XXXX anticoagulant therapy.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity117 :: ('MESH:D001241', 'Chemical') :: ['aspirin'] @entity260 :: ('MESH:D011183', 'Disease') :: ['postoperative bleeding complications'] @entity3925 :: ('MESH:C503223', 'Chemical') :: ['rivaroxaban'] @entity86 :: ('MESH:D019106', 'Disease') :: ['Postoperative bleeding', 'postoperative bleeding']
@entity3925 :: (MESH:C503223,Chemical) :: ['rivaroxaban']
